Pulse Biosciences
Stage
IPO | IPOTotal Raised
$8MDate of IPO
5/18/2016Market Cap
0.11BStock Price
3.21About Pulse Biosciences
Pulse Biosciences, formerly Electroblate, is a development-stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES. NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. We believe that NPES can induce a variety of cellular responses including secretion, apoptosis and necrosis by modulating the NPES pulses, making it applicable to a wide variety of cell types and therapeutic applications. One of the more promising applications of NPES is the treatment of solid tumors, where pre-clinical data have shown that NPES provides effective local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells.
Missing: Pulse Biosciences's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Pulse Biosciences's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Pulse Biosciences
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pulse Biosciences is included in 3 Expert Collections, including Medical Devices.
Medical Devices
12,106 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Health IT
7,901 items
Pulse Biosciences Patents
Pulse Biosciences has filed 47 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- Fishing equipment
- Electrical engineering
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/18/2019 | 9/27/2022 | Transformers (electrical), Electric power conversion, Analog circuits, Electrical engineering, Transistor types | Grant |
Application Date | 12/18/2019 |
|---|---|
Grant Date | 9/27/2022 |
Title | |
Related Topics | Transformers (electrical), Electric power conversion, Analog circuits, Electrical engineering, Transistor types |
Status | Grant |
Latest Pulse Biosciences News
Dec 6, 2022
Pulse ( PLSE ) said her departure was not the result of any disagreements or matters related to policies or practices. The company will soon begin a search for her replacement. Recommended For You Newest To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Pulse Biosciences Frequently Asked Questions (FAQ)
Where is Pulse Biosciences's headquarters?
Pulse Biosciences's headquarters is located at 401 Wilshire Boulevard, Santa Monica.
What is Pulse Biosciences's latest funding round?
Pulse Biosciences's latest funding round is IPO.
How much did Pulse Biosciences raise?
Pulse Biosciences raised a total of $8M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.